LL-37 5MG

LL-37 5 mg — Research Overview

LL-37 is a human antimicrobial peptide belonging to the cathelicidin family, widely studied in laboratory and preclinical research settings. Researchers utilize LL-37 to investigate host-defense mechanisms, membrane interactions, and immune signaling pathways in controlled experimental models.

Its amphipathic structure allows interactions with cellular membranes and water environments, making it a valuable tool for studying peptide-membrane dynamics, antimicrobial mechanisms, and immune modulation at the molecular level. LL-37 expression is naturally influenced by factors such as vitamin D and fatty acids, providing a model to examine peptide regulation in various tissues, including skin, lung, and neutrophils.

Areas of Research Interest (Investigational Use Only)

• Antimicrobial Mechanisms: Investigated for interactions with bacterial and viral membranes in vitro.

• Immune Signaling & Modulation: Explored for effects on immune-related cellular pathways and peptide-mediated signaling.

• Wound Healing & Tissue Regeneration Models: Used in preclinical studies for mechanistic insights into peptide effects on tissue repair.

• Peptide-Membrane Interactions: Studied for structure-function relationships in amphipathic peptide dynamics.

• Comparative Peptide Research: Utilized to examine LL-37 alongside other antimicrobial or immune-modulatory peptides.

• Preclinical Mechanistic Studies: Employed to investigate fundamental biochemical, molecular, and cellular processes.

Important Notice

This compound is intended strictly for research and laboratory use only. It is not approved for human or veterinary use, and no claims are made regarding infection treatment, wound healing, autoimmune modulation, or therapeutic applications. References to biological activity are provided solely for educational and investigational purposes and do not constitute medical or health claims.